R33CA103595/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	1
2005	5
2006	3
2007	7
2008	7
2009	3
2010	1
2024	0

1

Biomarker discovery in epithelial ovarian cancer by genomic approaches.

Mok SC, Elias KM, Wong KK, Ho K, Bonome T, Birrer MJ. Mok SC, et al. Adv Cancer Res. 2007;96:1-22. doi: 10.1016/S0065-230X(06)96001-1. Adv Cancer Res. 2007. PMID: 17161674 Review.

2

Etiology and pathogenesis of epithelial ovarian cancer.

Mok SC, Kwong J, Welch WR, Samimi G, Ozbun L, Bonome T, Birrer MJ, Berkowitz RS, Wong KK. Mok SC, et al. Dis Markers. 2007;23(5-6):367-76. doi: 10.1155/2007/474320. Dis Markers. 2007. PMID: 18057520 Free PMC article. Review.

3

Ovarian cancer is a heterogeneous disease.

Wang V, Li C, Lin M, Welch W, Bell D, Wong YF, Berkowitz R, Mok SC, Bandera CA. Wang V, et al. Cancer Genet Cytogenet. 2005 Sep;161(2):170-3. doi: 10.1016/j.cancergencyto.2004.12.014. Cancer Genet Cytogenet. 2005. PMID: 16102589

4

Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.

Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, Berkowitz RS, Mok SC. Ghosh S, et al. Gynecol Oncol. 2010 Oct;119(1):114-20. doi: 10.1016/j.ygyno.2010.05.029. Epub 2010 Jul 8. Gynecol Oncol. 2010. PMID: 20619446 Free PMC article.

5

Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.

Litkouhi B, Litkouhi B, Fleming E, Welch WR, Berkowitz RS, Birrer MJ, Mok SC. Litkouhi B, et al. Gynecol Oncol. 2008 May;109(2):234-9. doi: 10.1016/j.ygyno.2008.01.031. Epub 2008 Mar 10. Gynecol Oncol. 2008. PMID: 18331757

6

RUNX3 protein is overexpressed in human epithelial ovarian cancer.

Nevadunsky NS, Barbieri JS, Kwong J, Merritt MA, Welch WR, Berkowitz RS, Mok SC. Nevadunsky NS, et al. Gynecol Oncol. 2009 Feb;112(2):325-30. doi: 10.1016/j.ygyno.2008.09.006. Epub 2008 Oct 19. Gynecol Oncol. 2009. PMID: 18937968

7

Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary.

Tsuda H, Bandera CA, Birrer MJ, Hashiguchi Y, Berkowitz RS, Mok SC. Tsuda H, et al. Oncology. 2004;67(3-4):291-9. doi: 10.1159/000081330. Oncology. 2004. PMID: 15557791

8

Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.

Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ. Wamunyokoli FW, et al. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):690-700. doi: 10.1158/1078-0432.CCR-05-1110. Clin Cancer Res. 2006. PMID: 16467078

9

Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.

Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A, Welch WR, Berkowitz RS, Mok SC. Birrer MJ, et al. J Clin Oncol. 2007 Jun 1;25(16):2281-7. doi: 10.1200/JCO.2006.09.0795. J Clin Oncol. 2007. PMID: 17538174

10

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, Lu KH, Sood AK, Gershenson DM, Mok SC, Birrer MJ. Bonome T, et al. Cancer Res. 2005 Nov 15;65(22):10602-12. doi: 10.1158/0008-5472.CAN-05-2240. Cancer Res. 2005. PMID: 16288054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year